These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Review. Reflections on amyloidosis in Papua New Guinea. Westermark P; Westermark GT Philos Trans R Soc Lond B Biol Sci; 2008 Nov; 363(1510):3701-5. PubMed ID: 18849285 [TBL] [Abstract][Full Text] [Related]
23. Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). Glenner GG N Engl J Med; 1980 Jun; 302(24):1333-43. PubMed ID: 6990257 [No Abstract] [Full Text] [Related]
24. Characterization of amyloid. Glenner GG; Terry WD Annu Rev Med; 1974; 25():131-5. PubMed ID: 4132883 [No Abstract] [Full Text] [Related]
25. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis. Hamer JP; Janssen S; van Rijswijk MH; Lie KI Eur Heart J; 1992 May; 13(5):623-7. PubMed ID: 1618203 [TBL] [Abstract][Full Text] [Related]
26. Permanganate oxidation of senile cerebral amyloid and its relationship to AA protein. Powers JM; Sullivan L; Rosenthal CJ Acta Neuropathol; 1982; 58(4):275-8. PubMed ID: 6760651 [TBL] [Abstract][Full Text] [Related]
27. Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis. Omoto M; Yokota T; Cui D; Hoshii Y; Kawano H; Gondo T; Ishihara T; Kanda T Med Mol Morphol; 2007 Jun; 40(2):88-94. PubMed ID: 17572844 [TBL] [Abstract][Full Text] [Related]
29. The pathogenesis and biochemistry of amyloidosis. Cohen AS; Connors LH J Pathol; 1987 Jan; 151(1):1-10. PubMed ID: 3550020 [TBL] [Abstract][Full Text] [Related]
30. The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract. Shah PL; Gillmore JD; Copley SJ; Collins JV; Wells AU; du Bois RM; Hawkins PN; Nicholson AG Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):134-42. PubMed ID: 12102609 [TBL] [Abstract][Full Text] [Related]
31. Hepatic amyloidosis: morphologic spectrum of histopathological changes in AA and nonAA amyloidosis. Sarsik B; Sen S; Kirdok FS; Akarca US; Toz H; Yilmaz F Pathol Res Pract; 2012 Dec; 208(12):713-8. PubMed ID: 23154038 [TBL] [Abstract][Full Text] [Related]
32. The cutaneous amyloidoses. Pathogenesis and therapy. Breathnach SM Arch Dermatol; 1985 Apr; 121(4):470-5. PubMed ID: 3883907 [No Abstract] [Full Text] [Related]
33. [Amyloidosis: protein thesaurismosis]. Tena X; Olivé A Med Clin (Barc); 1994 Sep; 103(9):348-56. PubMed ID: 7967897 [No Abstract] [Full Text] [Related]
34. Cell-to-cell transfer of SAA1 protein in a cell culture model of systemic AA amyloidosis. Claus S; Puscalau-Girtu I; Walther P; Syrovets T; Simmet T; Haupt C; Fändrich M Sci Rep; 2017 Mar; 7():45683. PubMed ID: 28361953 [TBL] [Abstract][Full Text] [Related]
36. AA amyloid quantification in biopsy samples from the stomach. Yamada T; Okuda Y Ann Clin Lab Sci; 2012; 42(1):3-6. PubMed ID: 22371903 [TBL] [Abstract][Full Text] [Related]
37. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. Lavie G; Zucker-Franklin D; Franklin EC J Exp Med; 1978 Oct; 148(4):1020-31. PubMed ID: 702058 [TBL] [Abstract][Full Text] [Related]
38. New insights into systemic amyloidosis: the importance of diagnosis of specific type. Picken MM Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662 [TBL] [Abstract][Full Text] [Related]
39. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product. Westermark GT; Sletten K; Grubb A; Westermark P Am J Pathol; 1990 Aug; 137(2):377-83. PubMed ID: 2386201 [TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin allotypes are not involved in systemic amyloidosis. Ockhuizen T; Westra H; Bijzet J; Post J; van Leeuwen M; van Rijswijk M J Rheumatol; 1985 Aug; 12(4):742-6. PubMed ID: 3932652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]